Maxcyte, Inc. financial data

Symbol
MXCT on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
9713 Key West Avenue,, Suite 400, Rockville, MD
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.26K % -20.9%
Quick Ratio 79.5 % +30.5%
Debt-to-equity 14.4 % +11.5%
Return On Equity -15.5 % -18.6%
Return On Assets -13.6 % -17%
Operating Margin -102 % -1.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 105M shares +1.53%
Common Stock, Shares, Outstanding 105M shares +1.64%
Entity Public Float 468M USD +14.4%
Common Stock, Value, Issued 1.05M USD +1.61%
Weighted Average Number of Shares Outstanding, Basic 105M shares +1.53%
Weighted Average Number of Shares Outstanding, Diluted 105M shares +1.53%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 45.4M USD +11.7%
Revenue from Contract with Customer, Excluding Assessed Tax 19.5M USD -23.7%
Research and Development Expense 24.4M USD +7.2%
Selling and Marketing Expense 28.2M USD +24.8%
General and Administrative Expense 29.6M USD +8.78%
Operating Income (Loss) -46.3M USD -13.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.38M USD +10.8%
Net Income (Loss) Attributable to Parent -35.4M USD -8.56%
Earnings Per Share, Basic -0.34 USD/shares -6.25%
Earnings Per Share, Diluted -0.09 USD/shares +10%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.5M USD -31.2%
Accounts Receivable, after Allowance for Credit Loss, Current 4.58M USD -39.8%
Inventory, Net 11.2M USD +1.26%
Assets, Current 176M USD -25.8%
Property, Plant and Equipment, Net 21.7M USD -10.7%
Operating Lease, Right-of-Use Asset 11M USD +13.9%
Other Assets, Noncurrent 640K USD +7.15%
Assets 251M USD -7.27%
Accounts Payable, Current 953K USD -40.5%
Liabilities, Current 12.3M USD -7.04%
Operating Lease, Liability, Noncurrent 17.7M USD +12.4%
Other Liabilities, Noncurrent 310K USD -76.3%
Liabilities 30.2M USD +0.05%
Retained Earnings (Accumulated Deficit) -195M USD -22.2%
Stockholders' Equity Attributable to Parent 221M USD -8.18%
Liabilities and Equity 251M USD -7.27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD -144%
Net Cash Provided by (Used in) Financing Activities 703K USD -51.7%
Net Cash Provided by (Used in) Investing Activities -14.4M USD -149%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 105M shares +1.64%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -24.3M USD -191%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 37.5M USD -31.2%
Deferred Tax Assets, Valuation Allowance 45.6M USD +38%
Operating Lease, Liability 18.5M USD +14.3%
Payments to Acquire Property, Plant, and Equipment 804K USD -48.4%
Lessee, Operating Lease, Liability, to be Paid 27.2M USD +13.6%
Operating Lease, Liability, Current 878K USD +76.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.23M USD +25.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.17M USD +25.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +15.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.71M USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.28M USD +25.2%
Deferred Tax Assets, Operating Loss Carryforwards 22.5M USD +0.78%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.34M USD +25.2%
Additional Paid in Capital 415M USD +3.93%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.38M USD +19.8%
Share-based Payment Arrangement, Expense 13.8M USD +4.95%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%